Showing 1,721 - 1,740 results of 16,814 for search '"cancer"', query time: 0.13s Refine Results
  1. 1721
  2. 1722
  3. 1723
  4. 1724

    Breast Metastasis in Esophagus Cancer: Literature Review and Report on a Case by Abdulaziz Ghibour, Osama Shaheen

    Published 2016-01-01
    “…Esophagus cancer metastases often involve locoregional lymph nodes, lung, bone, liver, and brain. …”
    Get full text
    Article
  5. 1725
  6. 1726

    DNA replication initiation drives focal mutagenesis and rearrangements in human cancers by Pierre Murat, Guillaume Guilbaud, Julian E. Sale

    Published 2024-12-01
    “…Abstract The rate and pattern of mutagenesis in cancer genomes is significantly influenced by DNA accessibility and active biological processes. …”
    Get full text
    Article
  7. 1727
  8. 1728
  9. 1729
  10. 1730
  11. 1731

    Spontaneous Regression of Metastatic Papillary Thyroid Cancer in a Lymph Node by Jien Shim, Jianyu Rao, Run Yu

    Published 2018-01-01
    “…Spontaneous regression of cancer is defined as disappearance of cancer in the absence of specific therapy. …”
    Get full text
    Article
  12. 1732
  13. 1733
  14. 1734
  15. 1735
  16. 1736

    P2X7 Receptor Function in Bone-Related Cancer by Elena Adinolfi, Francesca Amoroso, Anna Lisa Giuliani

    Published 2012-01-01
    “…Taken together these data point to a pivotal role for the P2X7 receptor in bone cancer biology.…”
    Get full text
    Article
  17. 1737

    Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer by Bengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, Tunc Morova, Chia-Chi Flora Huang, Betul Ersoy Fazlioglu, Ivan Pak Lok Yu, Batuhan M. Kalkan, Paloma Cejas, Sonia H. Y. Kung, Ladan Fazli, Akane Kawamura, Henry W. Long, Ceyda Acilan, Tamer T. Onder, Tugba Bagci-Onder, James T. Lynch, Nathan A. Lack

    Published 2025-02-01
    “…Abstract Enzalutamide is a potent second-generation antiandrogen commonly used to treat hormone-sensitive and castration-resistant prostate cancer (CRPC) patients. While initially effective, the disease almost always develops resistance. …”
    Get full text
    Article
  18. 1738
  19. 1739
  20. 1740